• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.12% Nasdaq Up 0.71%

    RXi Pharmaceuticals Corporation (RXII)

    -NasdaqCM
    0.63 Down 0.05(6.72%) Apr 24, 4:00PM EDT
    Add to Portfolio
    Prev Close:0.67
    Open:0.72
    Bid:0.64 x 100
    Ask:0.93 x 10000
    1y Target Est:4.63
    Beta:3.13
    Earnings Date:May 12 - May 18 (Est.)
    Day's Range:0.61 - 0.72
    52wk Range:0.61 - 4.30
    Volume:1,318,540
    Avg Vol (3m):786,473
    Market Cap:19.51M
    P/E (ttm):N/A
    EPS (ttm):-0.79
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RXII

    Comparison

    Symbol% ChgMkt Cap
    RXIIDown 6.72%19.51M
    ALNYUp 0.24%9.97B
    MRNADown 1.24%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):294.62
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.35
    Quarterly EPS Est (Mar-15) :-0.10
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering and developing therapies primarily in the areas of dermatology and ophthalmology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback